OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 590 results

Filters: MARV

Modeling natural coinfection in a bat reservoir shows modulation of Marburg virus shedding and spillover potential.
Amy J Schuh, Brian R Amman, Jonathan C Guito, James C Graziano, Tara K Sealy, Jonathan S Towner
PLoS Pathog. Mar 17, 2025.21(3):e1012901 Print-Electronic
Source:PubMed
PMID: 40096181 doi:10.1371/journal.ppat.1012901
Regulation of Marburg virus (MARV) budding by Nedd4.1: a different WW domain of Nedd4.1 is critical for binding to MARV and Ebola virus VP40.
Shuzo Urata, Jiro Yasuda
J Gen Virol. Jan, 2010.91(Pt 1):228-34 Print-Electronic
Source:PubMed
PMID: 19812267 doi:10.1099/vir.0.015495-0
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
Kathleen M Daddario-DiCaprio, Thomas W Geisbert, Ute Ströher, Joan B Geisbert, Allen Grolla, Elizabeth A Fritz, Lisa Fernando, Elliott Kagan, Peter B Jahrling, Lisa E Hensley, Steven M Jones, Heinz Feldmann
Lancet. Apr 29, 2006.367(9520):1399-404 Print
Source:PubMed
PMID: 16650649 doi:10.1016/S0140-6736(06)68546-2
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
Woolsey, C.; Cross, R. W.; Agans, K. N.; Borisevich, V.; Deer, D. J.; Geisbert, J. B.; Gerardi, C.; Lantham, T. E.; Fenton, K. A.; Egan, M.; Eldridge, J. H.; Geisbert, T. W.; Matassov, D.
biorxiv. 2022-01-23. Preprint
Source:biorxiv
PPRID: 10.1101/2022.01.22.477345v1 doi:NA
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Dana L Swenson, Kelly L Warfield, Tom Larsen, D Anthony Alves, Sadie S Coberley, Sina Bavari
Expert Rev Vaccines. May, 2008.7(4):417-29 Print
Source:PubMed
PMID: 18444889 doi:10.1586/14760584.7.4.417
A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
Zhang, Y.; Zhang, M.; Wu, H.; Wang, X.; Zheng, H.; Feng, J.; Wang, J.; Luo, L.; Xiao, H.; Qiao, C.; Li, X.; Zheng, Y.; Huang, W. J.; Wang, Y.; Wang, Y.; Shi, Y.; Feng, J.; Chen, G.
biorxiv. 2023-09-17. Preprint
Source:biorxiv
PPRID: 10.1101/2023.09.17.558100v1 doi:NA
A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
Zhang, Y.; Zhang, M.; Wu, H.; Wang, X.; Zheng, H.; Feng, J.; Wang, J.; Luo, L.; Xiao, H.; Qiao, C.; Li, X.; Zheng, Y.; Huang, W. J.; Wang, Y.; Wang, Y.; Shi, Y.; Feng, J.; Chen, G.
biorxiv. 2023-11-28. Preprint
Source:biorxiv
PPRID: 10.1101/2023.09.17.558100v2 doi:NA
Impact of Mengla virus proteins on human and bat innate immune pathways
Williams, C. G.; Gibbons, J. S.; Kieffer, T. R.; Luthra, P.; Edwards, M. R.; Basler, C. F.
biorxiv. 2019-07-01. Preprint
Source:biorxiv
PPRID: 10.1101/687400v1 doi:10.1128/JVI.00191-20
In-silico Structural and Molecular Docking-Based Drug Discovery Against Viral Protein (VP35) of Marburg Virus: A potent Agent of MAVD
Quazi, S.; Malik, J.; Capuzzo, A. M.; Suman, K. S.; Haider, Z.
biorxiv. 2021-02-10. Preprint
Source:biorxiv
PPRID: 10.1101/2021.02.09.430405v1 doi:NA
Jamaican fruit bats (Artibeus jamaicensis) competence for Ebola virus but not Marburg virus is driven by intrinsic differences in viral entry and IFN-I signaling antagonism.
Van Tol, S.; Port, J.; Fischer, R.; Gallogly, S.; Bushmaker, T.; Griffin, A.; Schulz, J. E.; Carmody, A. B.; Myers, L.; Crowley, D.; Falvo, C.; Riopelle, J.; Wickenhagen, A.; Clancy, C.; Lovaglio, J.; Shaia, C.; Saturday, G.; Prado-Smith, J.; Hr, Y.; Lack, J.; Martens, C.; Anzick, S.; Kendall, L.; Schountz, T.; Plowright, R.; Marzi, A.; Munster, V.
biorxiv. 2024-10-19. Preprint
Source:biorxiv
PPRID: 10.1101/2024.10.17.618736v1 doi:NA
0